[1]刘晓霞,陈晓宇.营养支持治疗对造血干细胞移植患者营养状态影响的研究进展[J].医学信息,2023,36(14):188-192.[doi:10.3969/j.issn.1006-1959.2023.14.041]
 LIU Xiao-xia,CHEN Xiao-yu.Research Progress on the Effect of Nutritional Support Therapy on Nutritional Status of Patients with Hematopoietic Stem Cell Transplantation[J].Journal of Medical Information,2023,36(14):188-192.[doi:10.3969/j.issn.1006-1959.2023.14.041]
点击复制

营养支持治疗对造血干细胞移植患者营养状态影响的研究进展()
分享到:

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
36卷
期数:
2023年14期
页码:
188-192
栏目:
综述
出版日期:
2023-07-15

文章信息/Info

Title:
Research Progress on the Effect of Nutritional Support Therapy on Nutritional Status of Patients with Hematopoietic Stem Cell Transplantation
文章编号:
1006-1959(2023)14-0188-05
作者:
刘晓霞陈晓宇
(广西壮族自治区人民医院药学部临床药学科,广西 南宁 530021)
Author(s):
LIU Xiao-xiaCHEN Xiao-yu
(Department of Pharmacy,the People’s Hospital of Guangxi Zhuang Autonomous Region,Nanning 530021,Guangxi,China)
关键词:
造血干细胞移植营养支持治疗肠道菌群
Keywords:
Hematopoietic stem cell transplantationNutritional support treatmentIntestinal flora
分类号:
R730.5
DOI:
10.3969/j.issn.1006-1959.2023.14.041
文献标志码:
A
摘要:
造血干细胞移植(HSCT)患者在接受放化疗治疗期间会出现消化和免疫功能紊乱,引起营养成分摄入减少、消化道功能降低以及肠道菌群失衡。营养支持治疗能够维持移植前后的营养状态,预防或减少移植后并发症。给予营养支持治疗能够改善HSCT患者的营养状况,通过调节肠道菌群来改善移植后并发症,影响体内细胞代谢物水平,降低移植后并发症发生风险。对HSCT患者行营养支持治疗过程中应关注可能伴发的导管相关性并发症、代谢并发症等。本文主要分析HSCT患者出现营养不良的原因,对近年来营养支持治疗对HSCT患者移植前后的营养状态和肠道菌群的影响进行综述。
Abstract:
During radiotherapy and chemotherapy treatment, hematopoietic stem cell transplantation (HSCT) patients can result in digestive and immune dysfunction, resulting in reduced nutrient intake, reduced digestive tract function and intestinal flora imbalance. Nutritional support therapy can maintain nutritional status before and after transplantation and prevent or reduce post-transplantation complications. Nutritional support therapy can improve the nutritional status of HSCT patients, improve post-transplantation complications by regulating intestinal flora, affect the level of cellular metabolites in vivo, and reduce the risk of post-transplantation complications. In the course of nutritional support therapy for patients with HSCT, attention should be paid to possible catheter-related complications and metabolic complications. This article mainly analyzes the causes of malnutrition in HSCT patients, and reviews the effects of nutritional support therapy on nutritional status and intestinal flora in HSCT patients before and after transplantation in recent years.

参考文献/References:

[1]McMillen KK,Coghlin-Dickson T,Adintori PA.Optimization of nutrition support practices early after hematopoietic cell transplantation[J].Bone Marrow Transplant ,2021,56(2):314-326.[2]Muratore E,Leardini D,Baccelli F,et al.Nutritional modulation of the gut microbiome in allogeneic hematopoietic stem cell transplantation recipients[J].Front Nutr,2022,9:993668.[3]Fuji S,Cheng J,Yakushijin K,et al.Nutritional support in allogeneic hematopoietic stem cell transplantation Asian perspective[J].Blood Cell Ther,2022,5(2):54-60.[4]Paviglianiti A.Endocrine and Metabolic Disorders after Hematopoietic Cell Transplantation[J].Turk J Haematol,2020,37(2):111-115.[5]De Filipp Z,Duarte RF,Snowden JA,et al.Metabolic syndrome and cardiovascular disease following hematopoietic cell transplantation: screening and preventive practice recommendations from CIBMTR and EBMT[J].Bone Marrow Transplant,2017,52(2):173-182.[6]Shalitin S,Pertman L,Yackobovitch-Gavan M,et al.Endocrine and Metabolic Disturbances in Survivors of Hematopoietic Stem Cell Transplantation in Childhood and Adolescence[J].Horm Res Paediatr,2018,89(2):108-121. [7]Concepcion NDP,Romberg EK,Phillips GS,et al.Imaging Assessment of Complications from Transplantation from Pediatric to Adult Patients: Part 2:Hematopoietic Stem Cell Transplantation[J].Radiol Clin North Am,2020,58(3):569-582.[8]中华医学会血液学分会干细胞应用学组.中国异基因造血干细胞移植治疗血液系统疾病专家共识(Ⅲ)——急性移植物抗宿主病(2020年版)[J].中华血液学杂志,2020,41(7):529-536.[9]Pessach I,Tsirigotis P,Nagler A.The gastrointestinal tract: properties and role in allogeneic hematopoietic stem cell transplantation[J].Expert Rev Hematol,2017,10(4):315-326. [10]Atilla E,Ataca Atilla P,Cengiz Seval G,et al.Current approach to early gastrointestinal and liver complications of hematopoietic stem cell transplantation[J].Turk J Gastroenterol,2019,30(2):122-131.[11]Iyama S,Tatsumi H,Shiraishi T,et al.Possible clinical outcomes using early enteral nutrition in individuals with allogeneic hematopoietic stem cell transplantation: A single-center retrospective study[J].Nutrition,2021,83:111093.[12]Zama D,Bossù G,Leardini D,et al.Insights into the role of intestinal microbiota in hematopoietic stem-cell transplantation[J].Ther Adv Hematol,2020,11: 2040620719896961.[13]Noor F,Kaysen A,Wilmes P,et al.The Gut Microbiota and Hematopoietic Stem Cell Transplantation: Challenges and Potentials[J].J Innate Immun,2019,11(5):405-415.[14]Fan Y,Pedersen O.Gut microbiota in human metabolic health and disease[J].Nat Rev Microbiol,2021,19(1):55-71. [15]Shono Y,Docampo MD,Peled JU,et al.Increased GVHD-related mortality with broad-spectrum antibiotic use after allogeneic hematopoietic stem cell transplantation in human patients and mice[J].Science Translational Medicine,2016,8(339):339ra71.[16]Liu C,Yang Y,Wu D,et al.Inflammation-Associated Cytokines IGFBP1 and RANTES Impair the Megakaryocytic Potential of HSCs in PT Patients after Allo-HSCT[J].Biol Blood Marrow Transplant,2018,24(6):1142-1151. [17]Hill GR,Koyama M.Cytokines and costimulation in acute graft-versus-host disease[J].Blood,2020,136(4):418-428.[18]Zhou Y,He Y,Xing W,et al.An abnormal bone marrow microenvironment contributes to hematopoietic dysfunction in Fanconi anemia[J].Haematologica,2017,102(6):1017-1027.[19]Zhang Z,He Y,Zhu XL,et al.Acute Cholecystitis Following Allogeneic Hematopoietic Stem Cell Transplantation: Clinical Features,Outcomes,Risk Factors,and Prediction Model[J].Transplant Cell Ther,2021,27(3):253e1-253e9.[20]Hirose EY,de Molla VC,Gon?觭alves MV,et al.The impact of pretransplant malnutrition on allogeneic hematopoietic stem cell transplantation outcomes[J].Clin Nutr ESPEN,2019,33:213-219.[21]Inden A,Tsukahara T,Tachibana E,et al.Effect of Early Nutritional Support on Quality of Life by EORTC QLQ-C30 in Allogeneic Hematopoietic Stem Cell Transplantation[J].Blood Cell Therapy,2022,5(4):107-115.[22]Yoshifuji K,Inamoto K,Kiridoshi Y,et al.Prebiotics protect against acute graft-versus-host disease and preserve the gut microbiota in stem cell transplantation[J].Blood Adv,2020,4(19):4607-4617.[23]Aoyama T,Yoshitsugu K,Fukaya M,et al.Benefit of Reducing Body Weight Loss with A Nutritional Support Pathway in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation[J].Med Sci Monit Basic Res,2019,25:187-198.[24]Reikvam H,Hatfield K,Bruserud ?覫.The pretransplant systemic metabolic profile reflects a risk of acute graft versus host disease after allogeneic stem cell transplantation[J].Metabolomics,2016,12(1):12.[25]Tvedt THA,Skaarud KJ,Tj?覬nnfjord GE,et al.The Systemic Metabolic Profile Early after Allogeneic Stem Cell Transplantation: Effects of Adequate Energy Support Administered through Enteral Feeding Tube[J].Biol Blood Marrow Transplant,2020,26(2):380-391.[26]Masetti R,Zama D,Leardini D,et al.The gut microbiome in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation[J].Pediatr Blood Cancer,2020,67(12):e28711. [27]Belda E,Voland L,Tremaroli V,et al.Impairment of gut microbial biotin metabolism and host biotin status in severe obesity: effect of biotin and prebiotic supplementation on improved metabolism[J].Gut,2022,71(12):2463-2480.[28]Peled JU,Gomes ALC,Devlin SM,et al.Microbiota as Predictor of Mortality in Allogeneic matopoietic-Cell Transplantation[J].N Engl J Med,2020,382(9):822-834.[29]Shallis RM,Terry CM,Lim SH.Changes in intestinal microbiota and their effects on allogeneic stem cell transplantation[J].Am J Hematol,2018,93(1):122-128.[30]Andersen S,Staudacher H,Weber N,et al.Pilot study investigating the effect of enteral and parenteral nutrition on the gastrointestinal microbiome post-allogeneic transplantation[J].Br J Haematol,2020,188(4):570-581.[31]Arends J,Bachmann P,Baracos V,et al.ESPEN guidelines on nutrition in cancer patients[J].Clin Nutr,2017,36(1):11-48. [32]Hills RD Jr,Pontefract BA,Mishcon HR,et al.Gut Microbiome: Profound Implications for Diet and Disease[J].Nutrients,2019,11(7):1613.[33]D’Amico F,Biagi E,Rampelli S,et al.Enteral Nutrition in Pediatric Patients Undergoing Hematopoietic SCT Promotes the Recovery of Gut Microbiome Homeostasis[J].Nutrients,2019,11(12):2958.[34]Barco S,Heuschen CB,Salman B,et al.Home parenteral nutrition-associated thromboembolic and bleeding events: results of a cohort study of 236 individuals[J].J Thromb Haemost,2016,14(7):1364-1373.[35]Cantón-Bulnes ML,Garnacho-Montero J.Practical approach to the management of catheter-related bloodstream infection[J].Rev Esp Quimioter,2019,32 Suppl 2(Suppl 2):38-41.[36]Herek TC,Menegazzo VR,Ogaki MB,et al.Biofilm formation by blood isolates of Candida parapsilosis sensu stricto in the presence of a hyperglycidic solution at comparable concentrations of total parenteral nutrition[J].Rev Soc Bras Med Trop,2019,52:e20180182.[37]Kreymann KG,Heyland DK,de Heer G,et al.Intravenous fish oil in critically ill and surgicalpatients-Historical remarks and critical appraisal[J].Clin Nutr,2018,37(3):1075-1081.[38]Munshi L,Del Sorbo L,Adhikari NKJ,et al.Prone Position for Acute Respiratory Distress Syndrome. A Systematic Review and Meta-Analysis[J].Ann Am Thorac Soc,2017,114(Supplement_4):S280-S288.[39]Heidegger CP,Graf S,Perneger T,et al.The burden of diarrhea in the intensive care unit (ICU-BD). A survey and observational study of the caregivers’ opinions and workload[J].Int J Nurs Stud,2016,59:163-168.[40]Atasever AG,Ozcan PE,Kasali K,et al.The frequency, risk factors, and complications of gastrointestinal dysfunction during enteral nutrition in critically ill patients[J].Ther Clin Risk Manag,2018,14:385-391.

相似文献/References:

[1]孔令军,何海龙.不同方法治疗重型再生障碍性贫血儿童临床不良反应分析[J].医学信息,2018,31(24):59.[doi:10.3969/j.issn.1006-1959.2018.24.015]
 KONG Ling-jun,HE Hai-long.Analysis of Clinical Adverse Reactions in Children with Severe Aplastic Anemia Treated by Different Methods[J].Journal of Medical Information,2018,31(14):59.[doi:10.3969/j.issn.1006-1959.2018.24.015]
[2]彭裕连,谷加丽,王玉蕾,等.慢性肉芽肿病临床特点及预后分析[J].医学信息,2020,33(01):190.[doi:10.3969/j.issn.1006-1959.2020.01.064]
 PENG Yu-lian,GU Jia-li,WANG Yu-lei,et al.Clinical Characteristics and Prognosis of Chronic Granulomatous Disease[J].Journal of Medical Information,2020,33(14):190.[doi:10.3969/j.issn.1006-1959.2020.01.064]
[3]金秋颖.幼年型粒单核细胞白血病的发病机制及诊治[J].医学信息,2020,33(21):51.[doi:10.3969/j.issn.1006-1959.2020.21.015]
 JIN Qiu-ying.Pathogenesis, Diagnosis and Treatment of Juvenile Myelomonocytic Leukemia[J].Journal of Medical Information,2020,33(14):51.[doi:10.3969/j.issn.1006-1959.2020.21.015]
[4]肖 莉,宋 萍.造血干细胞移植的手术编码探讨及案例分析[J].医学信息,2020,33(20):1.[doi:10.3969/j.issn.1006-1959.2020.20.001]
 XIAO Li,SONG Ping.Discussion and Case Analysis of Surgical Coding for Hematopoietic Stem Cell Transplantation[J].Journal of Medical Information,2020,33(14):1.[doi:10.3969/j.issn.1006-1959.2020.20.001]
[5]邓 慧,侯著法,刘松山.肝脾T细胞淋巴瘤1例报告并文献复习[J].医学信息,2021,34(09):191.[doi:10.3969/j.issn.1006-1959.2021.09.053]
[6]孟 雪,吴婷婷,肖 毓,等.恶性食管瘘治疗现状的研究[J].医学信息,2022,35(02):43.[doi:10.3969/j.issn.1006-1959.2022.02.011]
 MENG Xue,WU Ting-ting,XIAO Yu,et al.Study on Treatment of Malignant Esophageal Fistula[J].Journal of Medical Information,2022,35(14):43.[doi:10.3969/j.issn.1006-1959.2022.02.011]
[7]石 莹,高 丽,于俊叶,等.净化舱内造血干细胞移植患者不同治疗阶段心理体验及支持需求质性研究的Meta整合[J].医学信息,2023,36(17):15.[doi:10.3969/j.issn.1006-1959.2023.17.003]
 SHI Ying,GAO Li,YU Jun-ye,et al.Meta- synthesis of Qualitative Research on Psychological Experience and Support Needs of Patients with Hematopoietic Stem Cell Transplantation in Purified Cabin at Different Treatment Stages[J].Journal of Medical Information,2023,36(14):15.[doi:10.3969/j.issn.1006-1959.2023.17.003]

更新日期/Last Update: 1900-01-01